Computational pharmacology study of tougu xiaotong granule in preventing and treating knee osteoarthritis.
- Author:
Chun-song ZHENG
1
;
Hong-zhi YE
;
Xiao-jie XU
;
Xian-xiang LIU
Author Information
- Publication Type:Journal Article
- MeSH: Animals; Anti-Inflammatory Agents; therapeutic use; Drugs, Chinese Herbal; therapeutic use; Osteoarthritis, Knee; drug therapy; prevention & control
- From: Chinese journal of integrative medicine 2009;15(5):371-376
- CountryChina
- Language:English
-
Abstract:
OBJECTIVETo study the pharmacological properties of Tougu Xiaotong Granule (TGXTG) in preventing and treating knee osteoarthritis (KOA) at the molecular level.
METHODSThe computational methods, including principal component analysis, molecular docking, target-ligand space distribution, and the predictions of absorption, distribution, metabolism, excretion and toxicity (ADMET), were introduced to characterize the molecules in TGXTG.
RESULTSThe structural properties of molecules in TGXTG were more: diverse than those of the drug/drug-like molecules, and TGXTG could interact with significant target enzymes related to KOA. In addition, the cluster of effective components was preliminarily identified by the target-ligand space distributions. As to the results of ADMET properties, some of them were unsatisfactory, and were merely regarded as references here.
CONCLUSIONBased on this computational pharmacology study, TGXTG is a broad-spectrum recipe inhibiting many important target enzymes, which could effectively postpone the degeneration of spectrum cartilage by coordinately inhibiting the biological effects of cytokines, matrix metallopeptidase 3, and oxygen free radicals. radicals.